These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 28034889)

  • 1. Alteration of blood clotting and lung damage by protamine are avoided using the heparin and polyphosphate inhibitor UHRA.
    Kalathottukaren MT; Abraham L; Kapopara PR; Lai BF; Shenoi RA; Rosell FI; Conway EM; Pryzdial EL; Morrissey JH; Haynes CA; Kizhakkedathu JN
    Blood; 2017 Mar; 129(10):1368-1379. PubMed ID: 28034889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Polymer Therapeutic Having Universal Heparin Reversal Activity: Molecular Design and Functional Mechanism.
    Kalathottukaren MT; Abbina S; Yu K; Shenoi RA; Creagh AL; Haynes C; Kizhakkedathu JN
    Biomacromolecules; 2017 Oct; 18(10):3343-3358. PubMed ID: 28880550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The toxicology of heparin reversal with protamine: past, present and future.
    Sokolowska E; Kalaska B; Miklosz J; Mogielnicki A
    Expert Opin Drug Metab Toxicol; 2016 Aug; 12(8):897-909. PubMed ID: 27223896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of reversal activity and mechanism of action of UHRA, andexanet, and PER977 on heparin and oral FXa inhibitors.
    Kalathottukaren MT; Creagh AL; Abbina S; Lu G; Karbarz MJ; Pandey A; Conley PB; Kizhakkedathu JN; Haynes C
    Blood Adv; 2018 Aug; 2(16):2104-2114. PubMed ID: 30135185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rheological and clot microstructure evaluation of heparin neutralization by UHRA and protamine.
    Yeh HH; Yu K; Vappala S; Kalathottukaren MT; Abbina S; Luo HD; Grecov D; Kizhakkedathu JN
    J Mech Behav Biomed Mater; 2021 Dec; 124():104851. PubMed ID: 34600430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Andexanet Alfa, the Possible Alternative to Protamine for Reversal of Unfractionated Heparin.
    Maneno JN; Ness GL
    Ann Pharmacother; 2021 Feb; 55(2):261-264. PubMed ID: 32667214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Affinity-based design of a synthetic universal reversal agent for heparin anticoagulants.
    Shenoi RA; Kalathottukaren MT; Travers RJ; Lai BF; Creagh AL; Lange D; Yu K; Weinhart M; Chew BH; Du C; Brooks DE; Carter CJ; Morrissey JH; Haynes CA; Kizhakkedathu JN
    Sci Transl Med; 2014 Oct; 6(260):260ra150. PubMed ID: 25355700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutralase reverses the anti-coagulant but not the anti-thrombotic activity of heparin in a rabbit model of venous thrombosis.
    Silver PJ; Broughton R; Bouthillier J; Quinn TA; Wallace AM; Weishaar RE
    Thromb Res; 1998 Aug; 91(3):143-50. PubMed ID: 9733158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low molecular weight protamine as nontoxic heparin/low molecular weight heparin antidote (III): preliminary in vivo evaluation of efficacy and toxicity using a canine model.
    Lee LM; Chang LC; Wrobleski S; Wakefield TW; Yang VC
    AAPS PharmSci; 2001; 3(3):E19. PubMed ID: 11741270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticoagulant and side-effects of protamine in cardiac surgery: a narrative review.
    Boer C; Meesters MI; Veerhoek D; Vonk ABA
    Br J Anaesth; 2018 May; 120(5):914-927. PubMed ID: 29661409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Andexanet Alfa Neutralizes the Anticoagulant Effects of Unfractionated Heparin of Bovine, Ovine and Porcine Origin Almost as Protamine Sulfate.
    Siddiqui F; Hoppensteadt D; Jeske W; Ramacciotti E; Tafur A; Fareed J
    Clin Appl Thromb Hemost; 2024; 30():10760296241247558. PubMed ID: 38656136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of high or low protamine dosing on postoperative bleeding following heparin anticoagulation in cardiac surgery. A randomised clinical trial.
    Meesters MI; Veerhoek D; de Lange F; de Vries JW; de Jong JR; Romijn JW; Kelchtermans H; Huskens D; van der Steeg R; Thomas PW; Burtman DT; van Barneveld LJ; Vonk AB; Boer C
    Thromb Haemost; 2016 Aug; 116(2):251-61. PubMed ID: 27277211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of regulating blood clotting with heparin and its antagonists on mast cells].
    Efimov VS; Rozkin MIa; Poberiĭ IA; Lindner DP
    Farmakol Toksikol; 1981; 44(1):80-5. PubMed ID: 7262304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nontoxic polyphosphate inhibitors reduce thrombosis while sparing hemostasis.
    Travers RJ; Shenoi RA; Kalathottukaren MT; Kizhakkedathu JN; Morrissey JH
    Blood; 2014 Nov; 124(22):3183-90. PubMed ID: 25202141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Adjusted Calculation Model Allows for Reduced Protamine Doses without Increasing Blood Loss in Cardiac Surgery.
    Kjellberg G; Sartipy U; van der Linden J; Nissborg E; Lindvall G
    Thorac Cardiovasc Surg; 2016 Sep; 64(6):487-93. PubMed ID: 26270199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coagulation protein function VI: augmentation of anticoagulant function by acetaldehyde-treated heparin.
    Brecher AS; Hellman K; Basista MH
    Dig Dis Sci; 1999 Jul; 44(7):1349-55. PubMed ID: 10489917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cationic derivative of dextran reverses anticoagulant activity of unfractionated heparin in animal models of arterial and venous thrombosis.
    Kalaska B; Sokolowska E; Kaminski K; Szczubialka K; Kramkowski K; Mogielnicki A; Nowakowska M; Buczko W
    Eur J Pharmacol; 2012 Jul; 686(1-3):81-9. PubMed ID: 22579410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protamine reversal of heparin affects platelet aggregation and activated clotting time after cardiopulmonary bypass.
    Mochizuki T; Olson PJ; Szlam F; Ramsay JG; Levy JH
    Anesth Analg; 1998 Oct; 87(4):781-5. PubMed ID: 9768770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low molecular weight protamine: a potent but nontoxic antagonist to heparin/low molecular weight protamine.
    Byun Y; Chang LC; Lee LM; Han IS; Singh VK; Yang VC
    ASAIO J; 2000; 46(4):435-9. PubMed ID: 10926141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of protamine overdose on coagulation parameters as measured by the thrombelastograph.
    Khan NU; Wayne CK; Barker J; Strang T
    Eur J Anaesthesiol; 2010 Jul; 27(7):624-7. PubMed ID: 20485179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.